Search

Joseph H. Murray

Examiner (ID: 1129)

Most Active Art Unit
1626
Art Unit(s)
1613, 1626
Total Applications
346
Issued Applications
321
Pending Applications
11
Abandoned Applications
14

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5581348 [patent_doc_number] => 20090176694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Reagents and Methods for Smooth Muscle Therapies' [patent_app_type] => utility [patent_app_number] => 12/101691 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15525 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176694.pdf [firstpage_image] =>[orig_patent_app_number] => 12101691 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/101691
Reagents and methods for smooth muscle therapies Apr 10, 2008 Issued
Array ( [id] => 7527426 [patent_doc_number] => 08044018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Reagents and methods for smooth muscle therapies' [patent_app_type] => utility [patent_app_number] => 12/101710 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15518 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044018.pdf [firstpage_image] =>[orig_patent_app_number] => 12101710 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/101710
Reagents and methods for smooth muscle therapies Apr 10, 2008 Issued
Array ( [id] => 5446923 [patent_doc_number] => 20090048149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Antagonists of the bradykinin B1 receptor' [patent_app_type] => utility [patent_app_number] => 12/082395 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25850 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048149.pdf [firstpage_image] =>[orig_patent_app_number] => 12082395 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082395
Antagonists of the bradykinin B1 receptor Apr 8, 2008 Abandoned
Array ( [id] => 4682790 [patent_doc_number] => 20080249016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Use of GLP-2 in a combination treatment for bone-related disorders' [patent_app_type] => utility [patent_app_number] => 12/082277 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37135 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249016.pdf [firstpage_image] =>[orig_patent_app_number] => 12082277 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082277
Use of GLP-2 in a combination treatment for bone-related disorders Apr 8, 2008 Abandoned
Array ( [id] => 8446297 [patent_doc_number] => 08288351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Antagonists of the bradykinin B1 receptor' [patent_app_type] => utility [patent_app_number] => 12/082224 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25884 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12082224 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082224
Antagonists of the bradykinin B1 receptor Apr 7, 2008 Issued
Array ( [id] => 5564599 [patent_doc_number] => 20090137452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Antagonists of the bradykinin B1 receptor' [patent_app_type] => utility [patent_app_number] => 12/082219 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25843 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137452.pdf [firstpage_image] =>[orig_patent_app_number] => 12082219 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082219
Antagonists of the bradykinin B1 receptor Apr 7, 2008 Issued
Array ( [id] => 4954469 [patent_doc_number] => 20080187493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Peptide-Based Compounds' [patent_app_type] => utility [patent_app_number] => 12/053829 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11336 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187493.pdf [firstpage_image] =>[orig_patent_app_number] => 12053829 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/053829
Peptide-based compounds Mar 23, 2008 Issued
Array ( [id] => 6492841 [patent_doc_number] => 20100093640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'ACE-INHIBITORY PEPTIDES FROM WHEY AND METHODS FOR PROVIDING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/529566 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8158 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093640.pdf [firstpage_image] =>[orig_patent_app_number] => 12529566 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/529566
ACE-INHIBITORY PEPTIDES FROM WHEY AND METHODS FOR PROVIDING THE SAME Mar 5, 2008 Abandoned
Array ( [id] => 6275254 [patent_doc_number] => 20100256061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'GASTRIN COMPOUND FOR DIABETES TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/529601 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25907 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256061.pdf [firstpage_image] =>[orig_patent_app_number] => 12529601 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/529601
GASTRIN COMPOUND FOR DIABETES TREATMENT Feb 28, 2008 Abandoned
Array ( [id] => 6454132 [patent_doc_number] => 20100105628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE' [patent_app_type] => utility [patent_app_number] => 12/526011 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8612 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105628.pdf [firstpage_image] =>[orig_patent_app_number] => 12526011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/526011
REDUCING POST-OPERATIVE ADHESION FORMATION WITH INTRAPERITONEAL GLUTAMINE Feb 13, 2008 Abandoned
Array ( [id] => 4808272 [patent_doc_number] => 20080171850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents' [patent_app_type] => utility [patent_app_number] => 11/969174 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25031 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171850.pdf [firstpage_image] =>[orig_patent_app_number] => 11969174 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/969174
Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents Jan 2, 2008 Abandoned
Array ( [id] => 4779651 [patent_doc_number] => 20080287649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Methods for the synthesis of cyclic peptides' [patent_app_type] => utility [patent_app_number] => 12/004265 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10485 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287649.pdf [firstpage_image] =>[orig_patent_app_number] => 12004265 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/004265
Methods for the synthesis of cyclic peptides Dec 19, 2007 Abandoned
Array ( [id] => 5337859 [patent_doc_number] => 20090054323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Specific Binding Agents of Human Angiopoietin-2' [patent_app_type] => utility [patent_app_number] => 11/952738 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 48567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054323.pdf [firstpage_image] =>[orig_patent_app_number] => 11952738 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/952738
Specific binding agents of human angiopoietin-2 Dec 6, 2007 Issued
Array ( [id] => 4704203 [patent_doc_number] => 20080063727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 11/979148 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6993 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20080063727.pdf [firstpage_image] =>[orig_patent_app_number] => 11979148 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/979148
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid Oct 30, 2007 Abandoned
Array ( [id] => 8282893 [patent_doc_number] => 08216995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Botulinum toxin treatments' [patent_app_type] => utility [patent_app_number] => 11/932524 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4301 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932524 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/932524
Botulinum toxin treatments Oct 30, 2007 Issued
Array ( [id] => 4675683 [patent_doc_number] => 20080213312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'BOTULINUM TOXIN TREATMENTS' [patent_app_type] => utility [patent_app_number] => 11/932435 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4302 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213312.pdf [firstpage_image] =>[orig_patent_app_number] => 11932435 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/932435
BOTULINUM TOXIN TREATMENTS Oct 30, 2007 Abandoned
Array ( [id] => 6220052 [patent_doc_number] => 20100055147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'ANGIOTENSIN (1-7) ELUTING STENT' [patent_app_type] => utility [patent_app_number] => 12/447415 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6999 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055147.pdf [firstpage_image] =>[orig_patent_app_number] => 12447415 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/447415
ANGIOTENSIN (1-7) ELUTING STENT Oct 25, 2007 Abandoned
Array ( [id] => 4846563 [patent_doc_number] => 20080182971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS' [patent_app_type] => utility [patent_app_number] => 11/876258 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11180 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182971.pdf [firstpage_image] =>[orig_patent_app_number] => 11876258 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/876258
PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS Oct 21, 2007 Abandoned
Array ( [id] => 4880373 [patent_doc_number] => 20080153756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Novel Peptides and Methods for the Treatment of Inflammatory Disorders' [patent_app_type] => utility [patent_app_number] => 11/874356 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14195 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153756.pdf [firstpage_image] =>[orig_patent_app_number] => 11874356 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/874356
Novel Peptides and Methods for the Treatment of Inflammatory Disorders Oct 17, 2007 Abandoned
Array ( [id] => 4879285 [patent_doc_number] => 20080152668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Thymosin Alpha 1 Peptide/Polymer Conjugates' [patent_app_type] => utility [patent_app_number] => 11/865816 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2754 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152668.pdf [firstpage_image] =>[orig_patent_app_number] => 11865816 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/865816
Thymosin Alpha 1 Peptide/Polymer Conjugates Oct 1, 2007 Abandoned
Menu